Rapid PE Triage and Notification (PETN) vs Zio XT ECG Monitoring System
AI Verdict
Choose Rapid PE Triage and Notification (PETN) if…
Choose Rapid PE Triage and Notification (PETN) if your primary need is the immediate, AI-powered detection and rapid clinician notification of suspected central pulmonary embolisms from CTPA scans. This tool is ideal for emergency departments and critical care settings where accelerating the diagnostic pathway for acute PE is crucial for timely intervention and improved patient outcomes.
View Rapid PE Triage and Notification (PETN) →Choose Zio XT ECG Monitoring System if…
Choose the Zio XT ECG Monitoring System if you require extended, continuous cardiac monitoring for up to 14 days to capture intermittent arrhythmias that may not be evident during shorter observation periods. This wearable solution is best suited for outpatient settings to diagnose patients experiencing infrequent symptoms such as palpitations, dizziness, or syncope, offering high patient compliance and comprehensive data for accurate diagnosis.
View Zio XT ECG Monitoring System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Rapid PE Triage and Notification (PETN) | Zio XT ECG Monitoring System |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing |
| Deployment | On-premise Rapid Server (dedicated or virtual) within hospital LAN/firewall, or Rapid Edge Cloud Platform. | Cloud-based (AWS EC2 platform), no on-premise hardware required. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Zio XT ECG Monitoring SystemTool B (Zio XT) excels in patient usability with its comfortable, lead-free, water-resistant wearable biosensor, leading to high patient compliance. While Tool A (Rapid PE Triage) streamlines clinician workflow, Tool B's innovative patient-centric design provides a stronger overall usability advantage, encompassing both patient and clinician experience.
Clinical Value
TieBoth tools offer significant and distinct clinical value, addressing critical needs in their respective domains. Tool A provides rapid, life-saving triage for acute pulmonary embolism, while Tool B offers extended, accurate detection of often elusive arrhythmias, both backed by clinical validation and FDA clearance.
Pricing & Value
Zio XT ECG Monitoring SystemTool B (Zio XT) offers significantly more transparency regarding its pricing structure, providing concrete per-patient costs in the UK and proposed Medicare rates in the US. Tool A (Rapid PE Triage) does not publicly disclose its pricing, making it harder for potential customers to assess its value proposition.
Enterprise Readiness
Rapid PE Triage and Notification (PETN)While both tools are FDA-cleared, HIPAA compliant, and have BAAs, Tool A (Rapid PE Triage) offers greater deployment flexibility with both on-premise server and cloud platform options. This caters to a wider range of enterprise IT infrastructures and security preferences, potentially making it more adaptable for diverse healthcare organizations.
Innovation
Zio XT ECG Monitoring SystemTool B (Zio XT)'s combination of a patient-friendly, long-duration wearable biosensor with advanced deep-learned AI for comprehensive arrhythmia detection represents a more disruptive and transformative innovation in ambulatory cardiac monitoring. While Tool A (Rapid PE Triage) innovatively applies AI to acute PE triage, Tool B fundamentally changes how extended cardiac monitoring is performed.
Support & Docs
TieBoth RapidAI and iRhythm Technologies appear to offer comprehensive support and documentation resources for their respective users. RapidAI mentions 24/7 support, while iRhythm provides FAQs, user manuals, and technical support contacts for clinicians and patients. The available information does not provide sufficient detail to definitively distinguish one as superior to the other in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Rapid PE Triage and Notification (PETN) | Zio XT ECG Monitoring System |
|---|---|---|
| Primary Function | AI-powered software analyzing CTPA images to rapidly identify and notify clinicians of suspected central pulmonary embolisms. | Wearable, single-lead ECG biosensor for up to 14 days of continuous cardiac monitoring, utilizing FDA-cleared AI and expert review for accurate arrhythmia detection and diagnosis. |
| Company | RapidAI (formerly iSchemaView) | iRhythm Technologies |
| Key Technology/Method | AI/ML module for CTPA image analysis; Detection of suspected central pulmonary embolism (PE); Real-time notifications. | Wearable single-lead ECG biosensor; Proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis. |
| Target Condition/Use Case | Suspected central pulmonary embolisms (PE). | Arrhythmia detection and diagnosis. |
| Monitoring Duration/Scope | Rapid analysis of CTPA images. | Up to 14 days of continuous cardiac monitoring. |
Videos
Demos, reviews, and walkthroughs featuring Rapid PE Triage and Notification (PETN) and Zio XT ECG Monitoring System.
Frequently Asked Questions
More Comparisons
More matchups featuring Rapid PE Triage and Notification (PETN) or Zio XT ECG Monitoring System
Backers
Who funded each tool's parent company.